Lixte Biotechnology Holdings, Inc. Common Stock

$5.13
+0.06 (+1.08%)

Volume:

86.946K ($446.03K)

Market Capitalization:

$59.60M

Lixte Biotechnology Holdings Price Chart

Lixte Biotechnology Holdings Price Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5.335.285.245.205.165.115.07

Lixte Biotechnology Holdings Volume Chart

Lixte Biotechnology Holdings Volume Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM15.02K12.88K10.73K8.58K6.44K4.29K2.15K

Lixte Biotechnology Holdings Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.17(+3.43%)
Open$4.96
Close$5.13
Low$4.75
Low Change-0.21 (-4.23%)
High$5.33
High Change+0.37 (+7.36%)
Range$0.58
Volume86.946K
Dollar Volume$446.03K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.02(-0.29%)
Open$5.09
Close$5.08
Low$4.85
Low Change-0.24 (-4.72%)
High$5.16
High Change+0.07 (+1.38%)
Range$0.31
Volume36.069K
Dollar Volume$183.05K

Premarket Yesterday

*No Trades in Segment

Lixte Biotechnology Holdings Moving Averages

5 Day Moving Average (SMA5)$5.06
10 Day Moving Average (SMA10)$4.45
20 Day Moving Average (SMA20)$4.04
50 Day Moving Average (SMA50)$3.38
100 Day Moving Average (SMA100)$3.40
200 Day Moving Average (SMA200)$3.91

Lixte Biotechnology Holdings Statistics

Average Volume (30 Days)51.69K
P/E Ratio (Current)-9.75
EPS (Current)-$0.52
Dividend Yield0.00%
Free Cash Flow
Cash Ratio3.83
Current Ratio3.88
Quick Ratio3.88
Debt to Equity0.00
Enterprise Value$53.80M
EV to EBITDA-10.53
EV to Sales
Price to Book6.10
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.48%
Return on Equity-0.63%

Lixte Biotechnology Holdings Stock Splits

There have been 2 stock splits for Lixte Biotechnology Holdings (LIXT). The last reverse stock split occured on June 5, 2023 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Jun 5, 2023Reverse10:1
Nov 20, 2020Reverse6:1

Lixte Biotechnology Holdings Dividends

There have been no dividends for Lixte Biotechnology Holdings (LIXT).